Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype
- PMID: 7987306
- DOI: 10.1093/hmg/3.8.1303
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype
Abstract
Von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign neoplasms, most frequently retinal, cerebellar and spinal haemangioblastoma, renal cell carcinoma, phaeochromocytoma and pancreatic tumours. We have previously detected large germline deletions by Southern analysis and pulsed field gel electrophoresis in 19% and 3% of VHL patients respectively. We have now investigated 94 VHL patients without large deletions for intragenic mutations using single strand conformation polymorphism and heteroduplex analysis. Forty different mutations were identified in 55 unrelated kindreds. A wide variety of mutations were detected including missense (n = 19), nonsense (n = 6), frameshift deletions or insertions (n = 12), in frame deletions (n = 2) and a splice donor site mutation (n = 1). The two most frequent mutations, were missense mutations at codon 238 (Arg-->Gln and Arg-->Trp) and were detected in five and four unrelated kindreds, respectively. VHL disease shows marked phenotypic variability and although phaeochromocytoma occurs in only about 7% of patients, marked interfamilial differences are observed. We examined the relationship between VHL gene mutations and phenotype in 65 kindreds. Large deletions or intragenic mutations predicted to cause a truncated protein were found in 36 of 53 families without phaeochromocytoma but only two of 12 families with phaeochromocytoma (chi 2 = 8.58; P < 0.01). Of 12 families with phaeochromocytoma 10 had missense mutations compared with 13 of 53 kindreds without phaeochromocytoma (chi 2 = 12.33; P < 0.001). In particular, substitution of an arginine at codon 238 (Arg-->Trp or Arg-->Gln) was associated with a high risk (62%) of phaeochromocytoma.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.J Med Genet. 1996 Apr;33(4):328-32. doi: 10.1136/jmg.33.4.328. J Med Genet. 1996. PMID: 8730290 Free PMC article.
-
Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan.Hum Mol Genet. 1995 Dec;4(12):2233-7. doi: 10.1093/hmg/4.12.2233. Hum Mol Genet. 1995. PMID: 8634692
-
Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.Hum Mol Genet. 1994 Apr;3(4):595-8. doi: 10.1093/hmg/3.4.595. Hum Mol Genet. 1994. PMID: 8069305
-
Von Hippel-Lindau disease and endocrine tumour susceptibility.Endocr Relat Cancer. 2006 Jun;13(2):415-25. doi: 10.1677/erc.1.00683. Endocr Relat Cancer. 2006. PMID: 16728571 Review.
-
Molecular genetic analysis of von Hippel-Lindau disease.J Intern Med. 1998 Jun;243(6):527-33. doi: 10.1046/j.1365-2796.1998.00334.x. J Intern Med. 1998. PMID: 9681854 Review.
Cited by
-
Hereditary neuroendocrine tumors of the gastroenteropancreatic system.Virchows Arch. 2007 Aug;451 Suppl 1:S29-38. doi: 10.1007/s00428-007-0450-3. Epub 2007 Aug 8. Virchows Arch. 2007. PMID: 17684762 Review.
-
von Hippel-Lindau disease: a clinical and scientific review.Eur J Hum Genet. 2011 Jun;19(6):617-23. doi: 10.1038/ejhg.2010.175. Epub 2011 Mar 9. Eur J Hum Genet. 2011. PMID: 21386872 Free PMC article. Review.
-
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.Mol Cell Biol. 1997 Sep;17(9):5629-39. doi: 10.1128/MCB.17.9.5629. Mol Cell Biol. 1997. PMID: 9271438 Free PMC article.
-
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6459-63. doi: 10.1073/pnas.92.14.6459. Proc Natl Acad Sci U S A. 1995. PMID: 7604013 Free PMC article.
-
Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting.J Med Genet. 2020 Aug;57(8):571-580. doi: 10.1136/jmedgenet-2019-106145. Epub 2020 Jun 19. J Med Genet. 2020. PMID: 32561571 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases